Short Seller Report Alleges ADMA Biologics Financial Misrepresentation

• ADMA Biologics stock is testing key support levels. What’s pressuring ADMA?Culper Research Describes ADMA Short; Alleges MisreportingThe report from Culper Research, released on Tuesday, alleges that ADMA Biologics has been misrepresenting its financial results and operating metrics.The firm disclosed that it holds a short position in ADMA, which adds a layer of skepticism to its claims.In response, ADMA Biologics emphasized its commitment to transparency and adherence to U.S. Securities and Exchange Com ...